Private equity’s growing influence on American health care has outpaced regulatory oversight. Stronger policies are necessary to safeguard patients, providers, and care delivery.
Holly Khachadoorian-Elia, MD, MBA
Advertisement
Articles by Holly Khachadoorian-Elia, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
ICER Draft Flags High Cost of New Hypertension Drug Class
4
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
5